NCT03652038
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Theravance Biopharma Investigational Site Manchester, England, United Kingdom
- Theravance Biopharma Investigational Site Belfast, Northern Ireland, United Kingdom